Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates

American Journal of Transplantation

Volumn 16, Issue 7, 2016, Pages 1958-1966

  Sapir Pichhadze, R ^a,b,c   Pintilie, M ^d   Tinckam, K J ^e,g,h   Laupacis, A ^f,h,i   Logan, A G ^e,f,g   Beyene, J ^f,j,k   Kim, S J ^e,f,g,l  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^k MCMASTER UNIVERSITY   (Canada)

^l ST MICHAEL'S HOSPITAL   (Canada)

more..

Author keywords

clinical research practice; epidemiology; health services and outcomes research; kidney transplantation nephrology; Scientific Registry for Transplant Recipients (SRTR); statistics

Indexed keywords

DECISION MAKING; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; KIDNEY GRAFT; MORTALITY; NONPARAMETRIC TEST; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURVIVAL ANALYSIS;

EID: 84976487727     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13717     Document Type: Review

References (40)

1. Sapir-Pichhadze R, Tinckam KJ, Laupacis A, Logan A, Beyene J, Kim S. Immune sensitization and mortality in wait-listed kidney transplant candidates. J Am Soc Nephrol 2016; 27: 570–578.
2. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: Possibilities and pitfalls. Int J Epidemiol 2012; 41: 861–870.
3. Pintilie M. Competing risks: A practical perspective. West Sussex, England: John Wiley & Sons, Ltd, 2006.
4. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695–706.
5. Alberti C, Metivier F, Landais P, Thervet E, Legendre C, Chevret S. Improving estimates of event incidence over time in populations exposed to other events: Application to three large databases. J Clin Epidemiol 2003; 56: 536–545.
6. Arce CM, Lenihan CR, Montez-Rath ME, Winkelmayer WC. Comparison of longer-term outcomes after kidney transplantation between Hispanic and non-Hispanic whites in the United States. Am J Transplant 2015; 15: 499–507.
7. Fonseca I, Teixeira L, Malheiro J, et al. The effect of delayed graft function on graft and patient survival in kidney transplantation: An approach using competing events analysis. Transpl Int 2015; 28: 738–750.
8. Smits JM, van Houwelingen HC, De Meester J, Persijn GG, Claas FH. Analysis of the renal transplant waiting list: Application of a parametric competing risk method. Transplantation 1998; 66: 1146–1153.
9. Kucirka LM, Grams ME, Lessler J, et al. Association of race and age with survival among patients undergoing dialysis. JAMA 2011; 306: 620–626.
10. An JN, Kim DK, Kim MH, et al. Elderly peritoneal dialysis compared with elderly hemodialysis patients and younger peritoneal dialysis patients: Competing risk analysis of a Korean prospective cohort study. PLoS ONE 2015; 10: 1–16.
11. Arce CM, Goldstein BA, Mitani AA, Lenihan CR, Winkelmayer WC. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol 2013; 8: 2149–2157.
12. Bailey RC, Jia-Yeong Lin M, Krakauer H. Time-to-event modeling of competing risks with intervening states in transplantation. Am J Transplant 2003; 3: 192–202.
13. Chang SH, Coates PT, McDonald SP. Effects of body mass index at transplant on outcomes of kidney transplantation. Transplantation 2007; 84: 981–987.
14. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170: 244–256.
15. Noordzij M, Leffondre K, Van Stralen KJ, Zoccali C, Dekker FW, Jager KJ. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant 2013; 28: 2670–2677.
16. Kaplan M. Nonparametric estimation from incomplete observations. J Amer Statist Assoc 1958; 53: 457–481.
17. Hosmer DWJ, Lemeshow S, May S. Applied survival analysis: Regression modeling of time to event data. Hoboken, NJ: John Wiley & Sons; 2008.
18. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Amer Statist Assoc 1993; 88: 400–409.
19. Pintilie M. Analysing and interpreting competing risk data. Stat Med 2007; 26: 1360–1367.
20. Verduijn M, Grootendorst DC, Dekker FW, Jager KJ, le Cessie S. The analysis of competing events like cause-specific mortality–beware of the Kaplan-Meier method. Nephrol Dial Transplant 2011; 26: 56–61.
21. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007; 26: 2389–2430.
22. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34: 541–554.
23. Gray RG. A class of k-sample tests for comparing the cumulative incidence of competing risk. Ann Stat 1988; 16: 1141–1154.
24. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993; 12: 737–751.
25. Cox DR. Regression models and life-tables. J R Stat Soc Series B 1972; 34: 187–220.
26. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Amer Statist Assoc 1999; 94: 496–509.
27. Baer HJ, Glynn RJ, Hu FB, et al. Risk factors for mortality in the nurses’ health study: A competing risks analysis. Am J Epidemiol 2011; 173: 319–329.
28. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489–495.
29. Karamlou T, Jang K, Williams WG, et al. Outcomes and associated risk factors for aortic valve replacement in 160 children: A competing-risks analysis. Circulation 2005; 112: 3462–3469.
30. Kasal DA, Barhoumi T, Li MW, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 2012; 59: 324–330.
31. Schiffrin EL. T lymphocytes: A role in hypertension? Curr Opin Nephrol Hypertens 2010; 19: 181–186.
32. Tambur AR, Leventhal JR, Walsh RC, Zitzner JR, Friedewald JJ. HLA-DQ barrier: Effects on cPRA calculations. Transplantation 2013; 96: 1065–1072.
33. Mishra MN, Baliga KV. Significance of panel reactive antibodies in patients requiring kidney transplantation. Saudi J Kidney Dis Transpl 2013; 24: 495–499.
34. Barama A, Oza U, Panek R, et al. Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants. Clin Transplant 2000; 14: 212–217.
35. Mizutani K.HLA mismatches and PRA in kidney retransplants. Clin Transpl 2007; 19–27.
36. Grams ME, Massie AB, Schold JD, Chen BP, Segev DL. Trends in the inactive kidney transplant waitlist and implications for candidate survival. Am J Transplant 2013; 13: 1012–1018.
37. Snappin S, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 2005; 59: 301–307.
38. Bayat S, Macher MA, Couchoud C, et al. Individual and regional factors of access to the renal transplant waiting list in France in a cohort of dialyzed patients. Am J Transplant 2015; 15: 1050–1060.
39. Coviello V, Boggess M. Cumulative incidence estimation in the presence of competing risks. Stata Journal 2004; 4: 103–112.
40. Cortese G, Andersen PK. Competing risks and time-dependent covariates. Biom J 2010; 52: 138–158.